- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow HBEAG Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 338972 [Title] => Hepatitis B treatment strategies [Summary] => Hepatitis B virus (HBV) is a transmissible, fibrogenic and oncogenic virus for which there are a continually expanding number of well-tolerated treatment options. The decision to treat patients with chronic hepatitis B (CHB) should be based on rapidly emerging data and knowledge of the clinical consensus regarding CHB. There is no way to predict reliably which patients will experience the sequelae of CHB complications of cirrhosis and hepatocellular carcinoma (HCC) or time-to-onset of these clinical endpoints. [DatePublished] => 2006-05-28 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 274759 [Title] => New hepa B treatment cited [Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
HBEAG
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 338972 [Title] => Hepatitis B treatment strategies [Summary] => Hepatitis B virus (HBV) is a transmissible, fibrogenic and oncogenic virus for which there are a continually expanding number of well-tolerated treatment options. The decision to treat patients with chronic hepatitis B (CHB) should be based on rapidly emerging data and knowledge of the clinical consensus regarding CHB. There is no way to predict reliably which patients will experience the sequelae of CHB complications of cirrhosis and hepatocellular carcinoma (HCC) or time-to-onset of these clinical endpoints. [DatePublished] => 2006-05-28 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 274759 [Title] => New hepa B treatment cited [Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 28, 2006 - 12:00am
April 21, 2005 - 12:00am
Recommended
Adamson fights for dear life against also-ran Ateneo today and will try to force a knockout match with the University of the East for the last Final Four ticket in the UAAP Season 87 men’s basketball at the Filoil EcoOil Centre in San Juan.
1 day ago
Adamson fights for its dear life against also-ran Ateneo with no more cards to play in a bid to force a knockout playoff with the University of the East for the last Final Four ticket in the UAAP Season 87 men’s basketball Saturday at the Filoil EcoOil Centre in San Juan.
1 day ago
University of the Philippines recovered mightily from another lethargic start and completed a vengeful 62-51 win over Centro Escolar University at the start of the first phase of the semis round in the PGFlex Invitational Basketball Tournament.
1 day ago
Once upon a time, there were basketball fans who believed that Scottie Thompson is not an effective basketball player on the international stage.
1 day ago
A week ago, Kai Sotto was still in the middle of concussion protocol. He was deemed questionable to play for Gilas Pilipinas, who is set to face World No. 22 New Zealand in the FIBA Asia Cup qualifiers.
2 days ago
Lotto Nov 23, 2024
EZ2/LVM - 7 25
SUERTRES - 0 8 2
6D Lotto - 2 3 1 5 7 1
6/42 - 18 2 40 42 26 14
P13,275,319.00
Grand Lotto - 4 17 26 9 41 7
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66